Goidel et al., v Aetna Life Insurance Company
US District Court, Southern District of New York
Case No. 1:21-cv-07619 (VSB)
Plaintiffs Emma Goidel, Ilana Lee, Madeleine Lee, and Lesley Brown (“Plaintiffs” or “Class Representatives”) filed a class action lawsuit against Aetna Life Insurance Company (“Defendant” or “Aetna”) on May 3, 2024. Plaintiffs filed the lawsuit on behalf of themselves and on behalf of the group or “Class” of persons who were allegedly discriminated against and denied equal access to fertility treatments as individuals in LGBTQ+ relationships. Defendant denies these allegations.
TO RECEIVE UPDATES TO THIS CASE PLEASE COMPLETE THIS FORM
OR
CHECK BACK FOR UPDATES TO THIS WEBSITE
FOR IMMEDIATE RELEASE October 10, 2024
CONTACT
Crystal Mojica, NWLC, cmojica@nwlc.org
Zoe Salzman, ECBAWM, zsalzman@ecbawm.com
Court Preliminarily Approves Aetna Settlement Guaranteeing Equitable Fertility Coverage for LGBTQ+ Families
NEW YORK, October 10, 2024 – In a landmark decision, the U.S. District Court for the Southern District of New York has preliminarily approved a settlement between Aetna and plaintiffs in Goidel v. Aetna, a federal class action addressing claims of discriminatory practices against LGBTQ+ policyholders seeking fertility treatments.
Under the settlement, Aetna will compensate individuals in the affected class, LGBTQ+ members of certain New York commercial and student insurance plans who were, or would have been, denied coverage for artificial insemination.
The lawsuit — filed in September 2021 by Emma Goidel, Ilana Lee, Madeleine Lee, and Lesley Brown — alleged that Aetna’s policies regarding artificial insemination and in vitro fertilization (IVF) discriminated against LGBTQ+ beneficiaries by subjecting them to higher out-of-pocket costs and longer waiting periods compared to heterosexual couples. The plaintiffs argued that these practices violated Section 1557 of the Affordable Care Act and various state and local laws.
Under settlement terms, if the settlement receives final court approval, Aetna will compensate members of the affected class as follows:
● Reprocess eligible insurance claims to reimburse class members for out-of-pocket expenses related to intrauterine insemination cycles paid for out-of-pocket, at a default amount of $2,300 per class member or up to the limits of their plans, whichever is greater.
● Establish a $2 million common fund to provide additional compensation to each class member.
● Cover all costs associated with the administrator and special master responsible for distributing the common fund.
Aetna has also implemented the following significant changes to its fertility coverage policies:
● Aligned its definition of infertility with the guidelines from the American Society for Reproductive Medicine, ensuring that all eligible plan members have equitable access to fertility treatments, regardless of sexual orientation.
● Introduced a new policy making intrauterine insemination a standard medical benefit covered for all members.
● Revised its requirements for progressing to IVF to ensure the treatment is more accessible for LGBTQ+ individuals.
“This decision solidifies a triumph for equitable access to healthcare services for everyone looking to build their families,” said Alison Tanner, senior litigation counsel for reproductive rights and health at the National Women’s Law Center. “We are ready to help affected class members receive the compensation they deserve, and we remain committed to advocating for equitable access to fertility treatments for all.”
“The Court’s preliminary approval allows us to move forward with distributing real compensation to the LGBTQ+ class members affected by this policy,” said Zoe Salzman, Partner at Emery Celli Brinckerhoff Abady Ward & Maazel LLP.